Multiplex Flow Immunoassay, T. Gondii, Rubella, Cmv Igm
PUQ is the FDA product code for Multiplex Flow Immunoassay, T. Gondii, Rubella, Cmv Igm, a class II device type, regulated under 21 CFR 866.3510. FDA's definition for this code reads: "The kit is a multiplex flow immunoassay intended for the qualitative detection of IgM antibodies to Toxoplasma gondii (T. gondii), Rubella, and Cytomegalovirus (CMV) in human serum and plasma". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- PUQ
- Device name
- Multiplex Flow Immunoassay, T. Gondii, Rubella, Cmv Igm
- FDA definition
- The kit is a multiplex flow immunoassay intended for the qualitative detection of IgM antibodies to Toxoplasma gondii (T. gondii), Rubella, and Cytomegalovirus (CMV) in human serum and plasma.
- Regulation
- 21 CFR 866.3510
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code PUQ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2017 | 1 |
Applicants with the most clearances
Product code PUQ| Applicant | Clearances |
|---|---|
| Bio-Rad Laboratories Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
